Chevy Chase Trust’s Allergan Inc AGN Stock Holding History

Chevy Chase Trust’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-226,804	Closed	-$48.2M	–	728
2014 Q4	$48.2M	Sell	226,804 -1,715	-0.8%	-$341K	0.3%	81
2014 Q3	$40.7M	Buy	228,519 +13,586	+6%	+$2.26M	0.26%	96
2014 Q2	$36.4M	Sell	214,933 -4,654	-2%	-$725K	0.25%	99
2014 Q1	$27.3M	Buy	219,587 +857	+0.4%	+$104K	0.2%	132
2013 Q4	$24.3M	Buy	218,730 +3,318	+2%	+$317K	0.18%	141
2013 Q3	$19.5M	Buy	215,412 +5,254	+3%	+$472K	0.16%	155
2013 Q2	$17.7M	Buy	+210,158	New	+$21.8M	0.15%	151

Other funds holding AGN

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Commerzbank Aktiengesellschaft Frankfurt, Germany $4.78B AUM 25.31% 1-Year Est. Return

ECM

Everence Capital Management Goshen, Indiana $1.64B AUM 26.46% 1-Year Est. Return

HFS

HL Financial Services Louisville, Kentucky $6.5B AUM 9.56% 1-Year Est. Return

AIM

Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Chevy Chase Trust's AGN Position: Q1 2015 in Review

Chevy Chase Trust sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 226,804 shares — an estimated $48.2M sold.

Chevy Chase Trust first reported a position in AGN in Q2 2013 and held it in 7 quarters. The position peaked at $48.2M in Q4 2014. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

Chevy Chase Trust reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
Chevy Chase Trust sold 226,804 Allergan Inc shares in Q1 2015, an estimated $48.2M.
Chevy Chase Trust first reported a position in Allergan Inc in Q2 2013 and held it in 7 quarters.
Chevy Chase Trust's Allergan Inc position peaked at $48.2M in Q4 2014.
5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on Chevy Chase Trust's 13F filing for Q1 2015, filed 15 Apr 2015.